Based on this statistically significant effect of treatment, which induced a negative correlation between Sufu and Gli, we propose that that vismodegib may sensitize medulloblastoma cells to the inhibitory effect of SUFU, such that cells with higher SUFU differentiate while cells with lower SUFU remain proliferative. The gene discussed is GLI1; the disease is medulloblastoma.